Candriam SCA’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-350,000	Closed	-$4.15M	–	708
2024 Q1	$4.15M	Buy	+350,000	New	+$4.15M	0.03%	373